Community Academic Profiles

Thomas Quertermous, MD

Academic Appointments

Contact Information

  • Academic Offices
    Personal Information
    Tel (650) 723-5013
    Administrative Contact
    Celest Landini Administrative Assistant Tel Work 650-723-5013

Professional Snapshot

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Consulting: Aviir, Incorporated , Via Pharmaceuticals
Equity: Via Pharmaceuticals
Service on Board of Directors: Aviir, Incorporated

Scientific Focus

Current Research Interests

The Quertermous laboratory employs two basic approaches of study to better understand the genetic basis of atherosclerotic heart disease. One approach uses basic molecular biology methodology, primarily working with cellular and genetic mouse models, and is focused on the recently identified apelin-APJ pathway. A second approach employs the power of modern human genetics. Informative cohorts have been collected that allow investigation of risk factors such as hypertension and insulin resistance as well as coronary heart disease. Initial studies have employed the candidate gene approach, and more recently whole genome association studies, to identify allelic variation that is associated with risk factor and disease susceptibility.

Stanford Medicine Resources:

Footer Links: